Corgenix Medical Corp-医療機器分野:企業M&A・提携分析

◆英語タイトル:Corgenix Medical Corp - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011107
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Corgenix Medical Corp (Corgenix), a subsidiary of Orgentec Diagnostika GmbH is a medical device company that offers medical diagnostic solutions. The company offers vascular disease products, infectious disease products, non-invasive liver biomarkers, and instrumentation. It offers an instrumentation line for use with the corgenix test kits in clinical testing laboratories. Corgenix products are developed for use in clinical laboratories for the diagnosis and monitoring of autoimmune disease, vascular disease and liver diseases, and others. The company also offers customer support solutions. It sells its products through a network of distributors across the US. Corgenix is headquartered in Broomfield, Colorado, the US.

Corgenix Medical Corp – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Corgenix Medical Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Corgenix Medical Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Corgenix Medical Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Corgenix Medical Corp, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Corgenix Medical Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Corgenix Medical Corp, Medical Equipment, Deal Details 10
Partnerships 10
Corgenix Medical Enters Into Licensing Agreement With Eiji Matsuura For AtherOx Technology 10
Corgenix Medical Enters into Product Development Agreement with Mellitus for Gestational Diabetes Test 11
Corgenix Medical Enters Into Co-Development Agreement With Zalgen Labs 12
Corgenix Medical Enters Into Co-Development Agreement With Health Diagnostic Lab 13
Corgenix Enters Into Co-Development Agreement With Eli Lilly 14
Acquisition 15
Orgentec Diagnostika to Acquire Corgenix Medical for USD16 Million 15
Corgenix Medical Corp – Key Competitors 17
Corgenix Medical Corp – Key Employees 18
Corgenix Medical Corp – Locations And Subsidiaries 19
Head Office 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Corgenix Medical Corp, Medical Equipment, Key Facts 2
Corgenix Medical Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Corgenix Medical Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Corgenix Medical Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Corgenix Medical Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Corgenix Medical Corp, Deals By Market, 2011 to YTD 2017 8
Corgenix Medical Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Corgenix Medical Enters Into Licensing Agreement With Eiji Matsuura For AtherOx Technology 10
Corgenix Medical Enters into Product Development Agreement with Mellitus for Gestational Diabetes Test 11
Corgenix Medical Enters Into Co-Development Agreement With Zalgen Labs 12
Corgenix Medical Enters Into Co-Development Agreement With Health Diagnostic Lab 13
Corgenix Enters Into Co-Development Agreement With Eli Lilly 14
Orgentec Diagnostika to Acquire Corgenix Medical for USD16 Million 15
Corgenix Medical Corp, Key Competitors 17
Corgenix Medical Corp, Key Employees 18

★海外企業調査レポート[Corgenix Medical Corp-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • GS Yuasa Corp (6674):企業の財務・戦略的SWOT分析
    GS Yuasa Corp (6674) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Ashoka Buildcon Ltd (ASHOKA):企業の財務・戦略的SWOT分析
    Ashoka Buildcon Ltd (ASHOKA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • GENEWIZ Inc:医療機器:M&Aディール及び事業提携情報
    Summary GENEWIZ Inc (GENEWIZ) is a provider of genomics and technical support services. The company’s services comprise next generation sequencing, sanger sequencing, gene synthesis, molecular genetics, cloning and mutagenesis, plasmid DNA preparation, oligo synthesis services and GLP-compliant serv …
  • Pentair plc (PNR)-石油・ガス分野:企業M&A・提携分析
    Summary Pentair plc (Pentair) is an industrial manufacturing company. It designs, manufactures and markets water system products and solutions for filtration, separation and fluid process management; and products that guard sensitive electrical and electronic equipment; and heat management solutions …
  • Oxiteno SA Industria E Comercio:企業の戦略的SWOT分析
    Oxiteno SA Industria E Comercio - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Polar Power Inc (POLA):企業の財務・戦略的SWOT分析
    Polar Power Inc (POLA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Old Dominion Electric Cooperative:企業の戦略的SWOT分析
    Old Dominion Electric Cooperative - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • HTC Corporation:戦略・SWOT・企業財務分析
    HTC Corporation - Strategy, SWOT and Corporate Finance Report Summary HTC Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Pearson plc:企業の戦略・SWOT・財務分析
    Pearson plc - Strategy, SWOT and Corporate Finance Report Summary Pearson plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Neurones SA (FR0004050250NRO):企業の財務・戦略的SWOT分析
    Neurones SA (FR0004050250NRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Epicor Software Corp:企業の戦略的SWOT分析
    Epicor Software Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • PPL Corporation (PPL):石油・ガス:M&Aディール及び事業提携情報
    Summary PPL Corp (PPL) is an energy holding company. Through its subsidiaries, LG&E, Kentucky Utilities, and KU Energy, it generates, transmits, distributes, and sells electricity; and distributes and sells natural gas. The company produces electricity from coal, natural gas, oil, hydro, and solar s …
  • Abbott Point of Care Inc:企業の製品パイプライン分析2018
    Summary Abbott Point of Care Inc (Abbott Point), a subsidiary of Abbott Laboratories, is a medical device company that offers diagnostic products. The company manufactures, develops, and distributes medical diagnostic and data management products for in-vitro diagnostic and healthcare markets. Its p …
  • Beacon Discovery Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Beacon Discovery Inc (Beacon Discovery) is an independent drug discovery incubator that focuses on identifying and advancing molecules targeting G-Protein Coupled Receptors (GPCRs) from concept to clinic. The company works in collaboration with pharma and biotech companies to discover and de …
  • Connect Catering Limited:企業の戦略・SWOT・財務情報
    Connect Catering Limited - Strategy, SWOT and Corporate Finance Report Summary Connect Catering Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Asahi Group Holdings Ltd:戦略・SWOT・企業財務分析
    Asahi Group Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Asahi Group Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Citizens Energy Group:企業の戦略的SWOT分析
    Citizens Energy Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Suda Ltd (SUD)-製薬・医療分野:企業M&A・提携分析
    Summary Suda Ltd (Suda) is a drug delivery company that offers oro-mucosal administration solutions. The company’s products include artimist, zolpimist, SUD-001, SUD-002, SUD-003, SUD-004 and SUD-005. Its artimist is a sub-lingual spray for the treatment of p. falciparum severe paediatric malaria. S …
  • Zumtobel Group AG (ZAG):企業の財務・戦略的SWOT分析
    Zumtobel Group AG (ZAG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Heidelberg Pharma AG (WL6)-製薬・医療分野:企業M&A・提携分析
    Summary Heidelberg Pharma AG(Heidelberg Pharma) formerly known as Wilex AG is a biopharmaceutical company with a focus on cancer. The company develops therapeutic and diagnostic product candidates for the treatment and specific detection of various cancers. It develops products based on and small mo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆